Vector Science & Therapeutics Corp. (TSXV: PAIN) ("Vector" or "Company") today announced the appointment of Dr. Alexander Dobranowski and Scott Kelly to its Board of Directors ("Board"), further ...

Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...

Based in San Francisco, Vector Capital invests in middle-market technology and technology-enabled businesses Vector was founded in 1997 Vector Capital has agreed to acquire San Francisco-based ...

SAN FRANCISCO--(BUSINESS WIRE)--Vector Capital (“Vector”), a leading private equity firm specializing in transformational investments in established technology businesses, today announced the ...

Introgen Therapeutic’s (Austin, TX) p53-based INGN 225 cancer vaccine yielded promising safety and efficacy results in a Phase II trial in advanced small cell lung cancer. The personalized therapeutic ...

Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...

IonQ said Wednesday the planned acquisition is intended to expand its quantum technology portfolio. By integrating Vector Atomic’s advanced PNT systems, including rackmount optical atomic clocks, ...

Crypto exchange Coinbase Global (COIN) agreed to acquire Vector, an onchain trading platform built on solana (SOL-USD), the company said on Friday. Integrating Vector's technology into Coinbase's ...

IonQ, a quantum computing technology company, has finalized the acquisition of quantum sensing firm Vector Atomic. IonQ said Tuesday the all-stock transaction enhances its position as a full-spectrum ...